[Question] Spain — has anyone got a straight answer on 503B
Genuine question, and the title is the question: Spain — has anyone got a straight answer on 503B.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Not medical advice, obviously, and nothing here is approved for human use. One person with a spreadsheet.
best — the order this archive was captured in
A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. The two are governed differently and the difference is not cosmetic.
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
salt forms are the recurring argument and the answer is boring
Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.
That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.
a 503B has to register and report, so there is a paper trail to ask for
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
ask which facility, then ask for their testing
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.
Is the compound still on the shortage list where you are?
Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.
Removed the staff name. Facilities and clinics can be named here; individuals cannot.
Not convinced. You are comparing a compounded concentration with a branded one and assuming they match.
the shortage list is the whole legal hinge and people skip it
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
- 1A 503A pharmacy compounds for an identified patient against a prescription.…7 comments in this branch · started by u/quiet_moderator
- 2The intake asked me three questions and none of them were about my history.…6 comments in this branch · started by u/escrow_evangelist